390 related articles for article (PubMed ID: 12447939)
1. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
Wagner KR; McPherron AC; Winik N; Lee SJ
Ann Neurol; 2002 Dec; 52(6):832-6. PubMed ID: 12447939
[TBL] [Abstract][Full Text] [Related]
2. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
4. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.
Patel K; Amthor H
Neuromuscul Disord; 2005 Feb; 15(2):117-26. PubMed ID: 15694133
[TBL] [Abstract][Full Text] [Related]
5. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
6. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice.
McCroskery S; Thomas M; Platt L; Hennebry A; Nishimura T; McLeay L; Sharma M; Kambadur R
J Cell Sci; 2005 Aug; 118(Pt 15):3531-41. PubMed ID: 16079293
[TBL] [Abstract][Full Text] [Related]
7. Alterations of temporalis muscle contractile force and histological content from the myostatin and Mdx deficient mouse.
Byron CD; Hamrick MW; Wingard CJ
Arch Oral Biol; 2006 May; 51(5):396-405. PubMed ID: 16263075
[TBL] [Abstract][Full Text] [Related]
8. Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality.
Li ZF; Shelton GD; Engvall E
Am J Pathol; 2005 Feb; 166(2):491-7. PubMed ID: 15681832
[TBL] [Abstract][Full Text] [Related]
9. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
[TBL] [Abstract][Full Text] [Related]
10. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.
Bartoli M; Poupiot J; Vulin A; Fougerousse F; Arandel L; Daniele N; Roudaut C; Noulet F; Garcia L; Danos O; Richard I
Gene Ther; 2007 May; 14(9):733-40. PubMed ID: 17330087
[TBL] [Abstract][Full Text] [Related]
11. Prolonged absence of myostatin reduces sarcopenia.
Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
[TBL] [Abstract][Full Text] [Related]
12. Muscle growth after postdevelopmental myostatin gene knockout.
Welle S; Bhatt K; Pinkert CA; Tawil R; Thornton CA
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E985-91. PubMed ID: 17148752
[TBL] [Abstract][Full Text] [Related]
13. Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies.
Castro-Gago M; Blanco-Barca MO; Eiris-Puñal J; Carneiro I; Arce VM; Devesa J
Pediatr Neurol; 2006 Apr; 34(4):281-4. PubMed ID: 16638502
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
15. First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
Burdi R; Didonna MP; Pignol B; Nico B; Mangieri D; Rolland JF; Camerino C; Zallone A; Ferro P; Andreetta F; Confalonieri P; De Luca A
Neuromuscul Disord; 2006 Apr; 16(4):237-48. PubMed ID: 16542837
[TBL] [Abstract][Full Text] [Related]
16. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
Taniguti AP; Pertille A; Matsumura CY; Santo Neto H; Marques MJ
Muscle Nerve; 2011 Jan; 43(1):82-7. PubMed ID: 21108244
[TBL] [Abstract][Full Text] [Related]
17. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
19. [Altered expression of myostatin gene in the progressive muscular dystrophy patients].
Zhang Y; Chen Y; Chen JW; Zhu DH
Yi Chuan Xue Bao; 2005 Aug; 32(8):779-83. PubMed ID: 16231730
[TBL] [Abstract][Full Text] [Related]
20. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle.
Gosselin LE; Williams JE; Deering M; Brazeau D; Koury S; Martinez DA
Muscle Nerve; 2004 Nov; 30(5):645-53. PubMed ID: 15389721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
